These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 34575977)
1. Industrially Compatible Transfusable iPSC-Derived RBCs: Progress, Challenges and Prospective Solutions. Lim ZR; Vassilev S; Leong YW; Hang JW; Rénia L; Malleret B; Oh SK Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575977 [TBL] [Abstract][Full Text] [Related]
2. Progresses in overcoming the limitations of in vitro erythropoiesis using human induced pluripotent stem cells. Ju H; Sohn Y; Nam Y; Rim YA Stem Cell Res Ther; 2024 May; 15(1):142. PubMed ID: 38750578 [TBL] [Abstract][Full Text] [Related]
3. In vitro erythrocyte production using human-induced pluripotent stem cells: determining the best hematopoietic stem cell sources. Cho YK; Kim HK; Kwon SS; Jeon SH; Cheong JW; Nam KT; Kim HS; Kim S; Kim HO Stem Cell Res Ther; 2023 Apr; 14(1):106. PubMed ID: 37101221 [TBL] [Abstract][Full Text] [Related]
4. Review: In vitro generation of red blood cells for transfusion medicine: Progress, prospects and challenges. Lee E; Sivalingam J; Lim ZR; Chia G; Shi LG; Roberts M; Loh YH; Reuveny S; Oh SK Biotechnol Adv; 2018 Dec; 36(8):2118-2128. PubMed ID: 30273713 [TBL] [Abstract][Full Text] [Related]
5. Erythropoietic properties of human induced pluripotent stem cells-derived red blood cells in immunodeficient mice. Deng J; Lancelot M; Jajosky R; Deng Q; Deeb K; Saakadze N; Gao Y; Jaye D; Liu S; Stowell SR; Cheng L; Roback JD Am J Hematol; 2022 Feb; 97(2):194-202. PubMed ID: 34779029 [TBL] [Abstract][Full Text] [Related]
6. Distinct gene expression program dynamics during erythropoiesis from human induced pluripotent stem cells compared with adult and cord blood progenitors. Merryweather-Clarke AT; Tipping AJ; Lamikanra AA; Fa R; Abu-Jamous B; Tsang HP; Carpenter L; Robson KJ; Nandi AK; Roberts DJ BMC Genomics; 2016 Oct; 17(1):817. PubMed ID: 27769165 [TBL] [Abstract][Full Text] [Related]
7. Activation of KLF1 Enhances the Differentiation and Maturation of Red Blood Cells from Human Pluripotent Stem Cells. Yang CT; Ma R; Axton RA; Jackson M; Taylor AH; Fidanza A; Marenah L; Frayne J; Mountford JC; Forrester LM Stem Cells; 2017 Apr; 35(4):886-897. PubMed ID: 28026072 [TBL] [Abstract][Full Text] [Related]
8. Generation of red blood cells from human embryonic/induced pluripotent stem cells for blood transfusion. Ebihara Y; Ma F; Tsuji K Int J Hematol; 2012 Jun; 95(6):610-6. PubMed ID: 22648827 [TBL] [Abstract][Full Text] [Related]
9. Generation of Red Blood Cells from Human Pluripotent Stem Cells-An Update. Lee SJ; Jung C; Oh JE; Kim S; Lee S; Lee JY; Yoon YS Cells; 2023 Jun; 12(11):. PubMed ID: 37296674 [TBL] [Abstract][Full Text] [Related]
10. A Scalable Suspension Platform for Generating High-Density Cultures of Universal Red Blood Cells from Human Induced Pluripotent Stem Cells. Sivalingam J; SuE Y; Lim ZR; Lam ATL; Lee AP; Lim HL; Chen HY; Tan HK; Warrier T; Hang JW; Nazir NB; Tan AHM; Renia L; Loh YH; Reuveny S; Malleret B; Oh SKW Stem Cell Reports; 2021 Jan; 16(1):182-197. PubMed ID: 33306988 [TBL] [Abstract][Full Text] [Related]
11. From stem cells to red blood cells: how far away from the clinical application? Xie X; Li Y; Pei X Sci China Life Sci; 2014 Jun; 57(6):581-5. PubMed ID: 24829108 [TBL] [Abstract][Full Text] [Related]
12. Accessory-cell-free differentiation of hematopoietic stem and progenitor cells into mature red blood cells. Boccacci Y; Dumont N; Doyon Y; Laganière J Cytotherapy; 2023 Nov; 25(11):1242-1248. PubMed ID: 37598334 [TBL] [Abstract][Full Text] [Related]
13. Modeling primitive and definitive erythropoiesis with induced pluripotent stem cells. Pavani G; Klein JG; Nations CC; Sussman JH; Tan K; An HH; Abdulmalik O; Thom CS; Gearhart PA; Willett CM; Maguire JA; Chou ST; French DL; Gadue P Blood Adv; 2024 Mar; 8(6):1449-1463. PubMed ID: 38290102 [TBL] [Abstract][Full Text] [Related]
14. In vitro production of transfusable red blood cells. Nakamura Y Biotechnol Genet Eng Rev; 2008; 25():187-201. PubMed ID: 21412356 [TBL] [Abstract][Full Text] [Related]
15. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors. Ramos-Mejía V; Montes R; Bueno C; Ayllón V; Real PJ; Rodríguez R; Menendez P PLoS One; 2012; 7(4):e35824. PubMed ID: 22545141 [TBL] [Abstract][Full Text] [Related]
16. Selection of O-negative induced pluripotent stem cell clones for high-density red blood cell production in a scalable perfusion bioreactor system. Yu S; Vassilev S; Lim ZR; Sivalingam J; Lam ATL; Ho V; Renia L; Malleret B; Reuveny S; Oh SKW Cell Prolif; 2022 Aug; 55(8):e13218. PubMed ID: 35289971 [TBL] [Abstract][Full Text] [Related]
17. Generation of red blood cells from induced pluripotent stem cells. Gunawardena N; Chou ST Curr Opin Hematol; 2024 May; 31(3):115-121. PubMed ID: 38362913 [TBL] [Abstract][Full Text] [Related]
18. Generation of red blood cells from human induced pluripotent stem cells. Dias J; Gumenyuk M; Kang H; Vodyanik M; Yu J; Thomson JA; Slukvin II Stem Cells Dev; 2011 Sep; 20(9):1639-47. PubMed ID: 21434814 [TBL] [Abstract][Full Text] [Related]
19. Recent updates of stem cell-based erythropoiesis. Han H; Rim YA; Ju JH Hum Cell; 2023 May; 36(3):894-907. PubMed ID: 36754940 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of Stem Cell-Derived Red Blood Cells as a Transfusion Product Using a Novel Animal Model. Shah SN; Gelderman MP; Lewis EM; Farrel J; Wood F; Strader MB; Alayash AI; Vostal JG PLoS One; 2016; 11(12):e0166657. PubMed ID: 27959920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]